Invited commentary

Ann Thorac Surg. 2006 Aug;82(2):492-3. doi: 10.1016/j.athoracsur.2006.01.085.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Cardiopulmonary Bypass / adverse effects*
  • Coronary Artery Bypass / adverse effects*
  • Humans
  • Myocardial Infarction / prevention & control*
  • Single-Chain Antibodies

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Single-Chain Antibodies
  • pexelizumab